Mind Medicine (MindMed) Inc.
MMED
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -3.00% | -16.04% | -7.48% | 6.70% | 6.58% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 44.02% | 19.60% | 10.71% | 9.46% | 11.81% |
Operating Income | -44.02% | -19.60% | -10.71% | -9.46% | -11.81% |
Income Before Tax | -12.23% | 38.06% | -13.52% | -27.39% | -35.45% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -12.23% | 38.06% | -13.52% | -27.39% | -35.45% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -12.23% | 38.06% | -13.52% | -27.39% | -35.45% |
EBIT | -44.02% | -19.60% | -10.71% | -9.46% | -11.81% |
EBITDA | -182.44% | -425.28% | -- | -410.41% | -49.43% |
EPS Basic | 39.67% | 67.80% | 26.26% | 0.06% | -7.76% |
Normalized Basic EPS | 40.60% | 66.60% | 24.81% | -1.72% | -9.44% |
EPS Diluted | 37.01% | 56.07% | 15.14% | -13.73% | -16.09% |
Normalized Diluted EPS | 40.96% | 67.16% | 25.23% | -1.20% | -9.19% |
Average Basic Shares Outstanding | 66.35% | 91.61% | 79.82% | 54.39% | 39.01% |
Average Diluted Shares Outstanding | 65.72% | 96.26% | 83.47% | 58.10% | 41.37% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |